Category Archives: Business and Investments

Latest From Business and Investments

Warning: Don’t Let Bio-Euphoria Distract You from Being Disciplined

DNA

This piece by Allan L. Shaw was originally published in Life Science Leader. We currently in a period I call “bio-euphoria,” in which the biopharmaceutical industry is experiencing growth in almost every area from market performance to patient-focused legislation. In parallel to this positive momentum, there has also been a notable shift in management and operational strategy by Big Pharma companies in an attempt to keep evolving with the market. These companies are taking creative Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

Discover Trends and Investment Opportunities at the BIO Investor Forum

hyde pier

The 2015 BIO Investor Forum in San Francisco is shaping up to be a must-attend event for private equity and public investors, research analysts, and industry executives focused on investment and business development opportunities in the life sciences. The Forum will include candid fireside chats between biopharma CEOs, analysts, and other industry experts. Come hear about recent company successes, what keeps the C-suite up at night, and where the industry’s leading companies are headed in 2016. Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

The Investment Landscape in Brazil

Rio de Janeiro, Brazil

Brazil has been at the forefront of biotech news recently, with China announcing plans to invest $250B and the recently signed Joint Communique with the U.S. government reaffirming their commitment to strengthening traditional ties, expand trade, and investment cooperation. Brazil is now one of the most attractive and promising biotech markets in the world—human health, agribusiness, raw materials and environmental—and investing in Brazil has become a new priority. Rather than leave innovation financing solely to Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

Academics Weigh In on Journal Article: “GMOs, Herbicides, and Public Health”

GMO soybeans

An article published in the New England Journal of Medicine by biotech critics Philip Landrigan and Charles Benbrook condemns the use of GMO crops and herbicides.  Ultimately, the authors offer a pair of personal recommendations calling for the EPA to delay its permit for Enlist Duo, a new combination herbicide comprising glyphosate plus 2,4-D; and urging for the mandatory labeling of GM foods. Push back on the article and Landrigan’s and Benbrook’s recommendations has been Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

Joint U.S.-Brazil Communique Demonstrates Commitment to Collaboration

Rio de Janeiro, Brazil

In June, Brazilian President Dilma Rousseff met with President Barack Obama to reaffirm their commitment to strengthening traditional ties, expand trade, and investment cooperation by issuing a Joint Communique which recognizes the work sharing potential of each country. This important milestone in U.S.-Brazilian diplomatic relations underscores the importance of supporting bilateral biofuels and biomedicine innovation by eliminating obstacles to the growth of investment, research and innovation. BIO invites you to learn more about the effect Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , ,